(84) |
Designated Contracting States: |
|
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR |
|
Designated Extension States: |
|
AL LT LV MK RO SI |
(30) |
Priority: |
10.02.2000 GB 0003092 09.02.2000 US 181377 P 03.05.2000 US 201989 P
|
(71) |
Applicants: |
|
- GLAXO GROUP LIMITED
Greenford, Middlesex UB6 ONN (GB)
- RUSH-PRESBYTERIAN-ST.LUKE'S MEDICAL CENTER
Chicago, IL 60612 (US)
|
|
(72) |
Inventors: |
|
- HUTCHINS, Jeff, T.
Chapel Hill, NC 27514 (US)
- KUETTNER, K. E.,Rush-Presbyterian St. Luke's M.C.
Chicago,IL 60612 (US)
- LINDLEY, K.M.,Glaxo Wellcome Inc.
Research Triangle Park, NC 27709 (US)
- SCHMID, T. M.,Rush-Presbyterian St. Luke's M.C.
Chicago, IL 60612 (US)
- SCHUMACHER, Barbara, L.
Cardiff by the Sea, CA 92007 (US)
- STIMPSON, Stephen, Anthony,Glaxo Wellcome Inc.
Research Triangle Park, NC 27709 (US)
- SU, Jui-Lan,Glaxo Wellcome Inc.
Research Triangle Park, NC 27709 (US)
|
(74) |
Representative: Giddings, Peter John, Dr. et al |
|
GlaxoSmithKlineCorporate Intellectual Property (CN9.25.1)980 Great West Road Brentford,Middlesex TW8 9GS Brentford,Middlesex TW8 9GS (GB) |
|